2024-11-07 21:11:46
Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia
Health/ 2023-07-22
Connect Biopharma Enhances its Intellect...

Novel,next-generation S1P1 agonist currently in Phase 2 clinical development for treatment of inflammatory bowel disease

InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal
Corporate/ 2023-07-23
InDex Pharmaceuticals Publishes Mechanis...

STOCKHOLM,Feb. 25,2020-- InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of acti...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release